Overall, the percentages of tumours which were found to express one of the peptides CRH, CRHR1, CRHR2 and FasL were 68.1, 70.2, 63.8 and 63.8%, respectively (examples of tissues positive or negative for one of the peptides are shown in Figure 1). This evidence concerns the gene CRHR1 and neoplasm.